New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
12:34 EDTCSCO, WMT, GTIV, KND, GM, NQ, ACXMOn The Fly: Midday Wrap
Stocks on Wall Street began the session in negative territory, extending yesterday's slide, and have remained there throughout the morning. The Dow is down about 1%, though that decline is less than either the S&P 500 or Nasdaq have experienced. The blue chip index is being weighed on by a post-earnings slide in shares of Wal-Mart (WMT), but that decline has been somewhat offset by the advance of fellow component Cisco (CSCO) after its own strong report. ECONOMIC EVENTS: In the U.S., initial claims fell to a new cycle-low 297K in the second week of May, which was below the expectation for 315K initial claims. The Consumer Price Index rose 0.3% in April compared to the prior month, as expected. The NY Fed's Empire State survey has a reading of 19.01, which was a four-year high and well above the forecast for a reading of 5.0. Industrial production fell 0.6% in April, which was worse than the expected decline of 0.1%. Capacity utilization fell to 78.6% in the month, which was also worse than expected. The Philadelphia Federal Reserve index fell to 15.4 in May from its prior reading of 16.6, which was a smaller decline than anticipated. The NAHB housing market index fell to 45 in May, undershooting the consensus estimate of 48. COMPANY NEWS: Two blue chip names were moving in different directions following their earnings reports, as tech giant Cisco lead all advancers on the Dow and the world's largest retailer, Wal-Mart, was the laggard on the index. Cisco shares gained almost 7% near noon after the company's Q3 results beat expectations and analysts at Cantor called the company's tone on its conference call "the most upbeat in over a year." Conversely, Wal-Mart fell 2.5% at midday after the company's earnings for the just ended quarter and its guidance for current quarter profits both trailed analysts' consensus forecast... General Motors (GM) shares are down nearly 3% after the company announced five new safety recalls covering about 2.7M vehicles in the United States. MAJOR MOVERS: Among the notable gainers was Gentiva Health (GTIV), which jumped 61% and was upgraded to Market Perform from Underperform at Raymond James after Kindred Healthcare (KND) made public its proposal to acquire Gentiva for a combination of $7.00 per share in cash and $7.00 of Kindred common stock. Shares of Kindred, which said that Gentiva has not been willing to discuss a transaction, also rose 6% after the announcement. Among the noteworthy losers was NetQin Mobile (NQ), which plunged 25% after the Chinese company, which has previously been accused of fraud by short-seller Muddy Waters, said it was unable to file its annual report on time because it needs additional time to complete it. Also lower was Acxiom (ACXM), which dropped 22% after the company gave a lower than expected FY15 outlook and announced a deal to acquire LiveRamp for $310M in cash. INDEXES: Near midday, the Dow was down 195.53, or 1.18%, to 16,418.44, the Nasdaq was down 60.36, or 1.47%, to 4,040.26, and the S&P 500 was down 25.16, or 1.33%, to 1,863.37.
News For CSCO;WMT;GTIV;KND;GM;NQ;ACXM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 10, 2014
10:01 EDTKNDOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:37 EDTWMTWal-Mart upgraded to Buy from Neutral at Gilford Securities
Subscribe for More Information
06:12 EDTGMGeneral Motors reports September China sales up 15.2% to 319,936
Subscribe for More Information
05:30 EDTGTIV, KNDKindred Healthcare upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
October 9, 2014
16:25 EDTGTIV, KNDOn The Fly: Closing Wrap
Subscribe for More Information
13:39 EDTCSCOCisco denies rumors that it will stop investing in VCE JV, The Register reports
Subscribe for More Information
13:37 EDTCSCOCisco may end further investment in VCE JV, CRN reports
Subscribe for More Information
12:30 EDTKND, GTIVOn The Fly: Midday Wrap
Subscribe for More Information
11:25 EDTCSCOCisco and TCL to set up $80M China cloud joint venture, Reuters reports
Subscribe for More Information
10:41 EDTKNDHigh option volume stocks
Subscribe for More Information
09:35 EDTKND, GTIVKindred Healthcare sees Gentiva deal closing in 1Q15
Subscribe for More Information
09:17 EDTGMOmix Ada recalls floor mats used in Chevrolet, GMC trucks, SUVs
Subscribe for More Information
08:46 EDTKND, GTIVKindred sees 'significant,' 'achievable' synergies from Gentiva deal
Kindred (KND) says it expects to issue in aggregate $620M-$720M of equity to maintain reasonable leverage. Says will issue Gentiva (GTIV) shareholders $200M in Kindred stock as part of purchase consideration, plans to raise $200M-$300M in equity and/or mandatory convertible securities between announcement and close. Says integration teams assembled, ready to be deployed immediately upon closing. Comments from slides that will be presented on Kindred's conference call discussing the proposed acquisition of Gentiva.
08:45 EDTGTIV, KNDGentiva volatility low into being acquired by Kindred for $1.8B
Subscribe for More Information
08:38 EDTKND, GTIVKindred volatility flat into acquiring Gentiva for $1.8B
Subscribe for More Information
08:27 EDTGTIV, KNDKindred sees Gentiva deal immediately and significantly accretive
Kindred (KND) expects the acquisition of Gentiva (GTIV) will be immediately and significantly accretive to earnings and operating cash flows, exclusive of transaction and integration costs. Kindred expects the acquisition to be approximately 40c-60c accretive to pro forma earnings, and pro forma operating cash flows of $350 million to $400 million, both on a run rate basis, once Gentiva is fully integrated and expected synergies are fully realized in the second full year following the closing. On this same basis, following the combined company’s expected annual maintenance capital expenditures of $120 million to $130 million, Kindred expects pro forma cash flows of $230 million to $270 million. Kindred has identified approximately $70 million of annual cost and operating synergies and expects to achieve the full run rate within two years of closing, of which approximately $35 million is expected to be achieved in the first year following the closing. Kindred expects the majority of cost synergies to be achieved through combining information technology functions, merging supply chains and eliminating redundant public company expenses. In addition, Kindred expects to realize revenue synergies that will improve patient care transitions and choice, and drive volume growth as a result of cross-selling across the combined service platform. Kindred expects annual run rate revenue synergies of more than $60 million over time, with approximately $20 million to $30 million achievable in the first full year following the closing.
08:26 EDTGTIV, KNDKindred Healthcare says combined company to operate in 47 states
Subscribe for More Information
08:25 EDTKND, GTIVKindred to acquire Gentiva for $19.50 per share in cash and stock, or $1.8B
Kindred Healthcare (KND) and Gentiva Health Services (GTIV) announced that the companies have entered into a definitive merger agreement under which Kindred will acquire all of the outstanding shares of Gentiva common stock for $19.50 per share in a combination of cash and stock. The agreement was unanimously approved by the boards of directors of both companies. Under the terms of the agreement, Gentiva shareholders will receive $14.50 per share in cash and $5.00 of Kindred common stock. The transaction is valued at $1.8 billion, including the assumption of net debt. The companies expect the closing of the transaction to occur in the first quarter of 2015. The combined company will: Employ approximately 109,000 individuals, making it the 78th largest private employer and the 4th largest healthcare employer in the United States; Deliver pro forma annual revenues of approximately $7.1 billion; and Generate pro forma operating income, including expected cost synergies, of $1.0 billion. Paul J. Diaz, CEO of Kindred, said, “Over the last eight weeks, we undertook a robust due diligence process and worked closely and constructively with our counterparts at Gentiva to better understand their operations, financial results and outlook. This process confirmed the compelling strategic rationale and industrial logic of this combination, as well as our belief that this transaction is in the best interests of both companies and our respective shareholders, patients, employees and business partners." Kindred has obtained committed financing from Citi and J.P. Morgan in connection with the pending transaction. Subject to market and other conditions, the Company expects to finance the acquisition of Gentiva and associated costs through the issuance of $200 million to $300 million of common stock and mandatory convertible equity securities and $1.3 billion to $1.4 billion of unsecured notes prior to the closing of the acquisition. The Company expects to fund the remaining amounts through its existing line of credit. Following completion of the transaction, Kindred expects to have approximately 85 million fully diluted shares outstanding, comprised primarily of approximately 64 million shares outstanding today, approximately 10 million shares to be issued to Gentiva as part of the transaction consideration, and approximately nine million to 12 million shares associated with the expected offering of common stock and mandatory convertible equity securities. The Gentiva acquisition is subject to certain conditions, including the approval by the stockholders of Gentiva. Kindred and Gentiva have already received clearance for the transaction under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
08:23 EDTGTIV, KNDKindred to acquire Gentiva for $19.50 per share in cash and stock
Subscribe for More Information
06:52 EDTCSCOTechnology producer settles China facility demonstrations, Reuters says
Hon Hai Precision Industry confirmed that it had settled a demonstration which involved close to 1K staff members at its Chongqing plant in China, and noted that manufacturing at the facility was not affected by the strike, according to Reuters, citing a statement from the company. Hon Hai constructs Apple (AAPL) products, as well as HP (HPQ) and Cisco (CSCO) computers and servers. The Chongqing facility isn't listed by Apple as one of its certified suppliers. Reference Link
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use